CLINICALLY ADJUSTED VERSUS THERAPEUTIC DRUG MONITORING DOSING REGIMENS WITH ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: RESULTS FROM THE SERENE-CD MAINTENANCE STUDY
Silvio Danese 1
William Sandborn 2
Edward V. Loftus Jr. 3
Stephen B Hanauer 4
Stefan Schreiber 5
Laurent Peyrin-Biroulet 6
Remo Panaccione
Julian Panés
Filip Baert
Jean-Frederic Colombel
Marc Ferrante
Edouard Louis
Alessandro Armuzzi
Sasikiran Goteti
John Liu
Nael M. Mostafa
Thao Doan
Joel Petersson
Anne M. Robinson
1 Humanitas Research Hospital,Rozzano,Italy
2 University of California San Diego,La Jolla,United States
3 Mayo Clinic,Rochester,United States
4 Feinberg School of Medicine, Northwestern University,Chicago,United States
5 Universität Kiel UKSH,Kiel,Germany
6 Nancy University Hospital Inserm U954 Department of Hepato-Gastroenterology,Vandoeuvr
Session
IBD: Drug monitoring
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]